The Latest Cardiac and Vascular News
– ENHANCE-IT study of MAT9001 against Vascepa® expected to be fully enrolled in August 2020; topline data anticipated Q1 2021 – – EnACT study of MAT2203 in cryptococcal meningitis resumed enrollment; on track for potential cohort progression Q4 2020 – – Management to host conference call today, Monday, August 10th, at […]
Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (“Acarix” or the “Company“) was held today on 11 August 2020 and the following resolutions were passed by the meeting. Approval of rights issue The extra general meeting resolved, in accordance with the board of directors’ proposal, […]
SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced the appointment of Katherine B. Quinn, Vice Chairman and Chief Administrative Officer of US Bancorp, a 70,000 employee and $547 Billion enterprise, to its Board of Directors. Mr. […]
Investments from Boehringer Ingelheim Venture Fund (BIVF), Playground Global and Initialized Capital will advance the prevention and management of heart disease SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced the close of an $11.2 million Series A investment round. Boehringer […]
Automated Imaging Analysis Technology Can Help Clinicians Provide Faster, Accurate Diagnoses; Integration Marks the Introduction of Zebra-Med’s Solution into the Modality Space TUSTIN, Calif.–(BUSINESS WIRE)–Building on its commitment to providing customers with Artificial Intelligence (AI) solutions that can be utilized across modalities in routine care, Canon Medical Systems USA, Inc. is partnering […]
VANCOUVER, CANADA, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 4,532,772 common shares at a purchase price of US$2.77575 […]
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the second quarter ended June 30, 2020, and provided a corporate update. “We have […]
Received FDA Acceptance of LIQ861 NDA for Review Reported Final Safety and Tolerability Results for LIQ861 INSPIRE Trial Appointed Tushar Shah, M.D. as Chief Medical Officer Announced Definitive Agreement to Acquire RareGen, LLC Completed Public Offering of Common Stock Company to Host Webcast and Conference Call Today at 4:30 p.m. ET […]
TEL AVIV, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that as of August 7, 2020, the Company has regained compliance with the […]
WHIPPANY, N.J.–(BUSINESS WIRE)–Lori Moore, former Managing Director at Deloitte, will be joining Bayer as Vice President, Head of Pharmaceutical Communications in the United States, the company announced today. Moore spent the last six years in senior communications roles at Deloitte, most recently as the Managing Director leading efforts to transform […]
